Mobile clinic and village doctors screening for heart failure in rural atrial fibrillation
Tests mobile clinic screening and village doctor care for heart failure in atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
Key facts
- Where
- Lianyungang, ChinaSee the site
Where in China
- Donghai County People's HospitalLianyungang, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jiangsu Taizhou People's Hospital
- Trial code
- NCT07896863
- Record updated
- 27 October 2026
- Original description
AF and HF frequently coexist and are associated with poor clinical outcomes. In rural areas, limited access to echocardiography, NT-proBNP testing, and specialist care may hinder the early identification and appropriate management of HF among patients with AF. Mobile clinics may help overcome these barriers by bringing diagnostic testing and specialist support directly to rural communities.Read full original descriptionShow less
Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
AF and HF frequently coexist and are associated with poor clinical outcomes. In rural areas, limited access to echocardiography, NT-proBNP testing, and specialist care may hinder the early identification and appropriate management of HF among patients with AF. Mobile clinics may help overcome these barriers by bringing diagnostic testing and specialist support directly to rural communities.
This cluster-randomized controlled trial aims to evaluate a mobile clinic-supported, village doctor-led model for HF screening and integrated management among older patients with AF in rural China. Mobile clinics equipped with echocardiography and NT-proBNP testing will support HF screening, and subsequent management will be tailored according to HF status. The study will evaluate whether this model can improve the detection of HF and reduce adverse cardiovascular events compared with routine management.
Inclusion: Permanent residents with local household registration at the primary level in Donghai County, aged ≥ 65 years; Electrocardiogram (ECG) confirmation of AF or possession of a diagnostic certificate for AF issued by a specialist; Management by a village clinic near the participant's place of residence; Ability to understand the study procedures and provide written informed consent.
Exclusion: Severe renal insufficiency (Ccr < 30ml/min) or ongoing dialysis treatment; Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease; Chronic obstructive pulmonary disease (COPD) complicated by type II respiratory failure; Special populations, including patients with mental illnesses; Expected life expectancy of less than 3 months; Indications for pacemaker implantation without having undergone implantation.